Array BioPharma, Deciphera, ImmunoGen initiated at Guggenheim

Guggenheim calls Array, Deciphera, ImmunoGen top biotech picks. Guggenheim initiated coverage of the biotechnology sector, initiating and assuming coverage of 17 biotechnology stocks, and saying it is bullish on the sector longer term and expects continued growth. The firm’s coverage focuses on the oncology therapeutic category, with Guggenheim calling Array Biopharma (ARRY), Deciphera Pharmaceuticals (DCPH), and ImmunoGen (IMGN), which all have key catalysts coming in the first half or 2019, its top picks.
https://thefly.com/landingPageNews.php?id=2791671